Biote announces $20M share repurchase authorization

biote Corp.

On Jan 25, 2024, board approved first-ever $20M share repurchase program for Class A common stock.
Repurchases may occur in open market, privately negotiated transactions, or via other means.
CEO cites strong balance sheet and confidence in growth opportunity as rationale for buyback.
Program may be modified, suspended, or discontinued at any time; no obligation to repurchase.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.